Literature DB >> 1838002

Differential foetal development of the O- and N-demethylation of codeine and dextromethorphan in man.

M G Ladona1, B Lindström, C Thyr, P Dun-Ren, A Rane.   

Abstract

1. Codeine and dextromethorphan were N-demethylated in human foetal liver microsomes at high rates which were close to the activities in adult livers. In contrast, foetal liver microsomes did not catalyze the O-demethylation of these drugs at mid-gestation. 2. The metabolic data were in accordance with the absence of P450IID6 and the presence of P450 IIIA as determined by Western blotting with anti-human P450 IID6 (MAb 114/2) and anti-rat P450 IIIA (PCN 2-13-1/C2) monoclonal antibodies, respectively. 3. The inhibitory effects of midazolam and dehydroepiandrosterone support the contention that the N-demethylase is a human foetal form of the cytochrome P450 IIIA family. Consistent with this we found that blotting with the MAb PCN 2-13-1/C2, which recognizes an epitope specific for the P450 III family, correlated well with the N-demethylase activities.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1838002      PMCID: PMC1368521          DOI: 10.1111/j.1365-2125.1991.tb03902.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  32 in total

1.  An improved procedure of the n-demethylation of 6,7-benzomorphans, morphine, and codeine.

Authors:  K C Rice
Journal:  J Org Chem       Date:  1975-06-13       Impact factor: 4.354

Review 2.  The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci.

Authors:  D W Nebert; D R Nelson; M Adesnik; M J Coon; R W Estabrook; F J Gonzalez; F P Guengerich; I C Gunsalus; E F Johnson; B Kemper
Journal:  DNA       Date:  1989 Jan-Feb

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Clinical significance of the sparteine/debrisoquine oxidation polymorphism.

Authors:  K Brøsen; L F Gram
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver.

Authors:  D S Davies; G C Kahn; S Murray; M J Brodie; A R Boobis
Journal:  Br J Clin Pharmacol       Date:  1981-01       Impact factor: 4.335

6.  Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI).

Authors:  P Dayer; J Desmeules; T Leemann; R Striberni
Journal:  Biochem Biophys Res Commun       Date:  1988-04-15       Impact factor: 3.575

7.  Absence of hepatic cytochrome P450bufI causes genetically deficient debrisoquine oxidation in man.

Authors:  U M Zanger; F Vilbois; J P Hardwick; U A Meyer
Journal:  Biochemistry       Date:  1988-07-26       Impact factor: 3.162

8.  Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: relationship to the presence of immunoidentified cytochrome P-450IID1.

Authors:  O Mortimer; K Persson; M G Ladona; D Spalding; U M Zanger; U A Meyer; A Rane
Journal:  Clin Pharmacol Ther       Date:  1990-01       Impact factor: 6.875

9.  Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences.

Authors:  L A Siddoway; K A Thompson; C B McAllister; T Wang; G R Wilkinson; D M Roden; R L Woosley
Journal:  Circulation       Date:  1987-04       Impact factor: 29.690

10.  Characterization of the common genetic defect in humans deficient in debrisoquine metabolism.

Authors:  F J Gonzalez; R C Skoda; S Kimura; M Umeno; U M Zanger; D W Nebert; H V Gelboin; J P Hardwick; U A Meyer
Journal:  Nature       Date:  1988-02-04       Impact factor: 49.962

View more
  10 in total

1.  O-demethylation of tramadol in the first months of life.

Authors:  Karel Allegaert; J N Van den Anker; R Verbesselt; J de Hoon; C Vanhole; D Tibboel; H Devlieger
Journal:  Eur J Clin Pharmacol       Date:  2005-11-08       Impact factor: 2.953

2.  Dextromethorphan differentially affects opioid antinociception in rats.

Authors:  Shiou-Lan Chen; Eagle Yi-Kung Huang; Lok-Hi Chow; Pao-Luh Tao
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

3.  Dextromethorphan metabolism in Jordanians: dissociation of dextromethorphan O-demethylation from debrisoquine 4-hydroxylation.

Authors:  Y M Irshaid; H F al-Hadidi; A Latif; F Awwadi; M al-Zoubi; N M Rawashdeh
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Oct-Dec       Impact factor: 2.441

Review 4.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions.

Authors:  J-D Maréchal; C A Kemp; G C K Roberts; M J I Paine; C R Wolf; M J Sutcliffe
Journal:  Br J Pharmacol       Date:  2007-11-19       Impact factor: 8.739

6.  Neonatal withdrawal syndrome due to maternal codeine use.

Authors:  Vrinda Nair; Amuchou Singh Soraisham; Albert Akierman
Journal:  Paediatr Child Health       Date:  2012-05       Impact factor: 2.253

7.  Human Fetal Liver Metabolism of Oxycodone Is Mediated by CYP3A7.

Authors:  Sara Shum; Nina Isoherranen
Journal:  AAPS J       Date:  2021-01-12       Impact factor: 4.009

8.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

9.  Developmental Pharmacogenetics of CYP2D6 in Chinese Children: Loratadine as a Substrate Drug.

Authors:  Qian Li; Yue-E Wu; Kai Wang; Hai-Yan Shi; Yue Zhou; Yi Zheng; Guo-Xiang Hao; Yi-Lei Yang; Le-Qun Su; Wen-Qi Wang; Xin-Mei Yang; Wei Zhao
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

Review 10.  Clinical pharmacology of midazolam in neonates and children: effect of disease-a review.

Authors:  Gian Maria Pacifici
Journal:  Int J Pediatr       Date:  2014-02-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.